Michael Christman to Speak on Personalized Medicine and the Human Genome at Chemical Heritage Foundation on December 1
November 22, 2011 - Philadelphia
Michael Christman, the president and chief executive officer of the Coriell Institute for Medical Research, will deliver the 22nd annual Ullyot Public Affairs Lecture at the Chemical Heritage Foundation, 315 Chestnut Street, Philadelphia. His lecture is entitled “Personalized Medicine and the Human Genome: What Your Doctor Should Know About Your Genes.” This free event begins promptly at 6 p.m. with a reception following at 7 p.m. Registration is required.
About Michael Christman
Soon after arriving at the institute, Christman established the Coriell Personalized Medicine Collaborative (CPMC), a forward-looking research study at the forefront of genome-informed medicine. The study’s truly collaborative team of physicians, scientists, ethicists, genetic counselors, pharmacists, information-technology experts, and volunteer study participants recognizes the promise of personalized medicine and seeks to guide its ethical, legal, and responsible implementation.
The CPMC study has been recognized by Health and Human Services secretary Michael Leavitt’s task force as a pioneer in personalized medicine. The combination of the CPMC’s unique study design and its focus on education, ethical conduct, and scientific validity has garnered much praise: Nature described the study as “leading by example,” and MIT Technology Review placed the CPMC on its 2010 “Top 10 Research Projects to Watch” list.
Under Christman’s leadership Coriell has also established a federally funded induced-pluripotent stem-cell laboratory. This remarkable technology allows a skin or blood cell to be coaxed into becoming nearly any cell type in the body, opening new avenues for research, drug discovery, and eventually therapy.
Christman has published articles in such scientific journals as Science, Nature, and Cell, and his work has been described in the New York Times, Wall Street Journal, and other media. He is a member of the Genetics Society of America, the New Jersey Technology Council Board of Directors, and the WHYY scientific advisory board.
About the Ullyot Public Affairs Lecture
The Ullyot Public Affairs Lecture was established in 1990 to emphasize to the general public the positive role that the chemical and molecular sciences play in our lives. Ullyot lectures are held annually and are open to the public. Ullyot lecturers are distinguished in their fields, nationally recognized, and able to communicate to a nonscientific audience.
The Ullyot Public Affairs Lecture is jointly sponsored by the Chemical Heritage Foundation, the Department of Chemistry at the University of Pennsylvania, the Department of Chemistry and Biochemistry at the University of the Sciences, and the Philadelphia Section and Delaware Section of the American Chemical Society.
About Glenn Edgar Ullyot
Glenn Edgar Ullyot earned a B.S. in chemistry from the University of Minnesota and an M.S. and a Ph.D. in chemistry from the University of Illinois. During a successful 38-year career with SmithKline & French Laboratories (now GlaxoSmithKline), Ullyot progressed through several stages of responsibility, from bench chemist to director of scientific liaison.
Ullyot’s primary scientific interests were with medicinal chemistry, therapeutic agents, and their biological activity. He published many papers, received patents on numerous compounds, and played a significant role in the development of several products, including Benzidrex, a nonstimulating analog of the inhaler Benzidrine, and Diazide, a diuretic agent for the treatment of high blood pressure.
Ullyot was an active member of and leader in the American Chemical Society for more than 60 years and served on several important U.S. governmental committees. Owing to his deep commitment to education, he established the Ullyot Public Affairs Lecture in 1990, stating, “Chemistry, biology, and physics are the basic sciences that are keys to understanding the world around us. It is my hope that each Ullyot lecturer will increasingly stimulate more people to appreciate the positive impact these sciences and the people who pursue them have on our daily lives.”
Ullyot lecturers are distinguished in their fields, nationally recognized, and able to communicate to a wide audience.
Past Ullyot Lecturers
• 2010 Susan Solomon
• 2009 Joseph M. DeSimone
• 2008 Bernard Bigot
• 2007 Shirley M. Tilghman
• 2006 Ralph J. Cicerone
• 2005 Marye Anne Fox
• 2004 Phillip A. Sharp
• 2003 Alfred Bader
• 2002 Jacqueline K. Barton
• 2001 Robert S. Langer
• 2000 Mark S. Wrighton
• 1999 George B. Rathmann
• 1998 Earnest W. Deavenport
• 1997 P. Roy Vagelos
• 1996 Harold E. Varmus
• 1995 Carl Djerassi
• 1994 Orlando A. Battista
• 1993 Bassam Z. Shakhashiri
• 1992 Maxine F. Singer
• 1991 Harry B. Gray
• 1990 Mary L. Good
About the Chemical Heritage Foundation
The Chemical Heritage Foundation (CHF) fosters an understanding of chemistry’s impact on society. An independent nonprofit organization, CHF strives to:
• Inspire a passion for chemistry;
• Highlight chemistry’s role in meeting current social challenges; and
• Preserve the story of chemistry and its technologies and industries across centuries.
CHF maintains major collections of instruments, fine art, photographs, papers, and books. The Foundation hosts conferences and lectures, supports research, offers fellowships, and produces educational materials. Its museum and public programs explore subjects ranging from alchemy to nanotechnology.
For more information, please visit chemheritage.org